FindTrial
Sign In

Clinical application value of multiple tests for novel coronavirus pneumonia (COVID-19)

Clinical application value of multiple tests for novel coronavirus pneumonia (COVID-19)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031428
Enrollment
Unknown
Registered
2020-03-31
Start date
2020-02-05
Completion date
Unknown
Last updated
2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Gold Standard:Viral nucleic acid detection
Index test:specific&#32
serological&#32
detection

Sponsors

Wuhan Asia heart Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Clinical manifestations of suspected Covid-19 such as fever and dry cough; 2. Pulmonary CT results indicate suspected Covid-19; 3. Apparently healthy physical examination subjects with a history of exposure to confirmed Covid-19 patients

Exclusion criteria

Exclusion criteria: lack of NAT or serologically specific antibody detection

Design outcomes

Primary

MeasureTime frame
SARS-CoV-2 antibody;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactZejin Liu

Wuhan Asia General Hospital

zejinliu@163.com+86 18963980043

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 27, 2026